Medpace Holdings ( (MEDP) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medpace Holdings shares are climbing after Jefferies said a rebound in biotech funding expected in late 2025 should fuel stronger bookings into late 2026 and ease concerns about slowing demand. The bank also argued that artificial intelligence is less of a near-term threat to the business than feared, which is helping improve investor sentiment.
On the back of these factors, Jefferies upgraded Medpace to Buy, pointing to a recent valuation reset and what it views as conservative company guidance. Together, these elements create what the firm sees as an attractive risk/reward profile ahead of a potential pickup in both demand and earnings.
More about Medpace Holdings
YTD Price Performance: -24.52%
Average Trading Volume: 279,359
Technical Sentiment Signal: Buy
Current Market Cap: $12.03B
For further insights into MEDP stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.